Sean McGrath

Sean McGrath

Auto-generated profile, based on publicly available information

Sean McGrath

Department of Biostatistics Yale School of Public Health New Haven Connecticut USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2019 in Biometrical Journal
Verified
Journal Article
Closed access
PDF file
SMSean McGrath
Sean McGrath
HSHojoon Sohn
Hojoon Sohn
RSRussell Steele
Russell Steele
ABAndrea Benedetti
Andrea Benedetti

20 November 2018 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
SMSean McGrath
Sean McGrath
XZXiaoFei Zhao
XiaoFei Zhao
ZQZhi Zhen Qin
Zhi Zhen Qin
RSRussell Steele
Russell Steele
ABAndrea Benedetti
Andrea Benedetti

1 June 2020 in Patterns
Verified
Journal Article
Open access
SMSean McGrath
Sean McGrath
VLVictoria Lin
Victoria Lin
ZZZilu Zhang
Zilu Zhang
LPLucia C. Petito
Lucia C. Petito
RLRoger W. Logan
Roger W. Logan
JYJessica G. Young
Jessica G. Young
Researchers are often interested in estimating the causal effects of sustained treatment strategies, i.e., of (hypothetical) interventions involving time-varying treatments. When using observational data, estimating those effects requires adjustment for confounding. However, conventional regression methods cannot appropriately adjust for confounding in the presence of treatment-confounder feedback. In contrast, estimators derived from Robins’s g-formula may correctly adjust for confounding even if treatment-confounder feedback exists. The package gfoRmula implements in R one such estimator: the parametric g-formula. This estimator can be used to estimate the effects of binary or continuous time-varying treatments as well as contrasts defined by static or dynamic, deterministic, or random interventions, as well as interventions that depend on the natural value of treatment. The package accommodates survival outcomes as well as binary or continuous outcomes measured at the end of follow-up. This paper describes the gfoRmula package, along with motivating background, features, and examples.

16 February 2022 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
AZAlexandra J. Zimmer
Alexandra J. Zimmer
FLFederica Lainati
Federica Lainati
NVNathaly Aguilera Vasquez
Nathaly Aguilera Vasquez
CCCarole Chedid
Carole Chedid
SMSean McGrath
Sean McGrath
MKMikashmi Kohli
Mikashmi Kohli
Current WHO recommendations for monitoring treatment response in adult pulmonary tuberculosis (TB) are sputum smear microscopy and/or culture conversion at the end of the intensive phase of treatment. These methods either have suboptimal accuracy or a long turnaround time.

26 May 2022 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
LBLukas E. Brümmer
Lukas E. Brümmer
SKStephan Katzenschlager
Stephan Katzenschlager
SMSean McGrath
Sean McGrath
SSStephani Schmitz
Stephani Schmitz
MGMary Gaeddert
Mary Gaeddert
CDClaudia Denkinger
Claudia Denkinger
Background: Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail. Methods and findings: We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients’ symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies’ heterogeneity in viral load assessment and sample origination. Conclusions: Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed.

10 December 2023 in Research Synthesis Methods
Verified
Journal Article
Closed access
SMSean McGrath
Sean McGrath
XZXiaoFei Zhao
XiaoFei Zhao
OOOmer Ozturk
Omer Ozturk
SKStephan Katzenschlager
Stephan Katzenschlager
RSRussell Steele
Russell Steele
ABAndrea Benedetti
Andrea Benedetti